Sunil Healthcare Ltd (BSE: 537253) is a New Delhi, Delhi-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹73 Cr, it ranks #3,506 by market cap among the 6,197 Indian listed companies on FinBizNet, and #71 of 86 in Medicinal Chemicals and Botanical Products. At ₹73.00 (as of 16 Nov 2026), the share price is 11.0% below its 52-week high of ₹82.00 and 21.7% above its 52-week low of ₹60.00. The share price is down 0.6% over one year and up 11.6% over three months.
| Current Price | ₹73.00 |
|---|---|
| Market Cap | ₹73 Cr |
| BSE Code | 537253 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 18.2 |
| Return on Equity | 5.86% |
| Return on Assets | 2.42% |
| 52-Week Range | ₹60.00 – ₹82.00 |
| 1-Year Price Change | -0.6% |
| 3-Month Price Change | +11.6% |
| Beta (1Y) | 0.23 |
| Headquarters | New Delhi, Delhi |
| Website | www.sunilhealthcare.com |
Delivery averaged 86.9% of traded volume across 15 NSE sessions (23 Oct 2026 – 13 Nov 2026).
Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul extracts. The company offers its products under the SUNLOC brand name. Sunil Healthcare Limited was incorporated in 1973 and is based in New Delhi, India.
1. Sale of Capsule-This segment manufactures and sells empty hard gelatin and HPMC capsule shells. 2. Marketing of Food Products - Discontinued Operations-This segment markets food products. 3. Unallocated Assets-0 4. Segment Adjustment-0
1. Sale of Capsule-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Sunil Healthcare Ltd | ₹73 Cr | 18.2 | 5.86% | — | -0.6% |
Listed by market capitalisation. Ratios are shown for context only.
Sunil Healthcare Ltd is trading at ₹73.00, with a market capitalisation of ₹73 Cr.
Sunil Healthcare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Sunil Healthcare Ltd has a P/E of 18.2 and a return on equity of 5.86%.
Sunil Healthcare Ltd is listed on the BSE under the scrip code 537253.
Sunil Healthcare Ltd's share price is down 0.6% over one year and up 11.6% over three months. Its 52-week range is ₹60.00 to ₹82.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.